AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting riskPopularity #3,968

DH · NASDAQ · Medical - Healthcare Information Services

Definitive Healthcare (DH)

Combines healthcare data and workflow tools for commercial teams.

$0.9094

vs last close+0.02 (+2.18%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	65	66	63	64	63	62	59	61	60	62	56	55
Cost of revenue	12	13	13	13	14	15	15	14	9	20	23	15
Gross profit	53	53	50	50	49	48	44	47	51	42	33	41
	349	63	67	420	274	147	229	51	60	−135	38	47
Research & development	11	12	10	10	7	9	9	8	8	10	6	0
	37	40	39	34	31	29	33	33	33	34	32	30
Selling & marketing	23	24	22	22	20	20	21	20	20	20	20	19
General & administrative	15	17	17	13	11	9	12	13	12	14	12	11
Other expenses	301	12	18	376	236	109	186	10	19	−180	0	17
Operating income	−295	−10	−16	−370	−225	−100	−185	−4	−9	177	−5	−7
	29	−2	3	42	24	9	19	−5	−9	−194	−191	−1
Interest income	3	4	4	4	4	3	2	2	2	1	1	1
Interest expense	4	4	4	4	4	4	2	3	3	3	3	3
Other non-operating income	−33	−2	−7	−45	−28	−12	−21	2	6	191	188	−2
Income before tax	−266	−12	−13	−328	−202	−91	−166	−9	−17	−17	−196	−8
Income tax expense	−18	1	−1	−22	−14	−6	−11	0	1	0	−3	0
Net income from continuing operations	−249	−13	−13	−306	−188	−85	−155	−9	−18	−17	−192	−7
Net income	−172	−10	−10	−214	−131	−59	−107	−8	−15	−9	−139	−5
EPS, basic	−$1.50	−$0.09	−$0.08	−$1.81	−$1.12	−$0.51	−$0.95	−$0.07	−$0.14	−$0.09	−$1.32	−$0.05
EPS, diluted	−$1.50	−$0.09	−$0.08	−$1.81	−$1.12	−$0.51	−$0.95	−$0.07	−$0.14	−$0.09	−$1.32	−$0.05
Weighted average shares, basic	115	116	117	118	116	115	113	107	104	103	105	106
Weighted average shares, diluted	115	116	117	118	116	115	113	107	104	103	105	106
EBITDA	−249	5	3	−312	−185	−74	−150	9	0	−5	−180	−5
Depreciation & amortization	13	13	13	13	13	13	14	14	14	9	13	0
EBIT	−262	−8	−10	−324	−198	−87	−164	−6	−14	−14	−193	−5